Eagan, Minn. – October 12, 2026 -- Solventum (NYSE: SOLV) said it intends to separate its Health Information Systems business, a healthcare software unit with $1.4 billion in annual sales, and is targeting completion within 12 to 18 months.

The move is the latest step in the company's three-phase transformation strategy. Solventum's Board of Directors and management expect the separation to leave a dedicated MedTech company focused on its MedSurg and Dental Solutions businesses.

Eagan, Minn. – October 12, 2026 -- Solventum raised its full-year 2026 adjusted EPS guidance to $7.10-$7.20 and announced its intent to separate its Health Information Systems business, after second-quarter organic sales rose 9.5%.